Florida International University, Herbert Wertheim College of Medicine, Florida, USA.
Department of Surgery, Miller School of Medicine, University of Medicine, Miami, Florida, USA.
Oxid Med Cell Longev. 2020 Sep 9;2020:3537675. doi: 10.1155/2020/3537675. eCollection 2020.
Surgical management of thyroid eye disease- (TED-) associated morbidity has been plagued by the complex interplay of different operative techniques. Orbital decompression is the well-recognized procedure for disfiguring exophthalmos and dysthyroid optic neuropathy (DON). There are numerous published techniques described for the removal of the orbital bone, fat, or a combination. The diverse studies are noncomparative as they include different indications, stages of disease, and methods of evaluation. Thus, it is difficult to conclude the most efficient decompression technique. To obtain effective and predictable results, it is therefore important to propose a logical and acceptable clinical guideline to customize patient treatment. Herein, we developed an algorithm based on the presence of DON, preoperative existing diplopia, and severity of proptosis which were defined by patient's disabling symptoms together with a set of ocular signs reflecting visual function or cosmesis. More specifically, we aimed to assess the minimal but effective surgical technique with acceptable potential complications to achieve therapeutic efficacy. Transcaruncular or inferomedial decompressions are indicated in restoring optic nerve function in patients with DON associated with mild or moderate to severe proptosis, respectively. Inferomedial or fatty decompressions are effective to treat patients with existing diplopia associated with mild or moderate to severe proptosis, respectively. Fatty or balanced decompressions can improve disfiguring exophthalmos in patients without existing diplopia associated with mild to moderate or severe proptosis, respectively. Inferomedial or 3-wall decompressions are preferred to address facial rehabilitation in patients associated with very severe proptosis but without preoperative diplopia.
甲状腺眼病(TED)相关并发症的手术治疗一直受到不同手术技术复杂相互作用的困扰。眼眶减压术是治疗明显眼球突出和甲状腺相关视神经病变(DON)的公认方法。有许多已发表的技术用于去除眶骨、脂肪或两者的组合。这些不同的研究是不可比较的,因为它们包括不同的适应证、疾病阶段和评估方法。因此,很难得出最有效的减压技术。为了获得有效和可预测的结果,因此,提出一个逻辑和可接受的临床指南来定制患者的治疗方案非常重要。在这里,我们根据 DON 的存在、术前存在的复视以及由患者的致残症状以及反映视觉功能或美容的一组眼部体征共同定义的眼球突出严重程度,制定了一种基于算法的方法。更具体地说,我们旨在评估具有最小但有效的手术技术,同时可接受潜在并发症,以实现治疗效果。经结膜或内侧下减压术分别适用于恢复与轻度或中度至重度眼球突出相关的 DON 患者的视神经功能。内侧下或脂肪减压术分别有效治疗与轻度或中度至重度眼球突出相关的存在复视的患者。脂肪或平衡减压术可改善与轻度至中度或重度眼球突出相关但无现有复视的患者的美容性眼球突出。内侧下或 3 壁减压术优先用于解决与严重眼球突出但无术前复视相关的面部康复问题。